Back
Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
52
CPRX
Catalyst Pharmaceuticals
Last Price:
21.85
Seasonality Move:
-2.32%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.Catalyst Pharmaceuticals Price Quote
$21.85
+0.08 (+0.37%)
(Updated: October 30, 2024 at 2:25 PM ET)
Catalyst Pharmaceuticals Key Stats
Buy
52
Catalyst Pharmaceuticals (CPRX)
is a Buy
Day range:
$21.56 - $22.20
52-week range:
$11.89 - $22.20
Dividend yield:
0%
P/E ratio:
34.56
P/S ratio:
5.87
P/B ratio:
4.25%
Volume:
639.1K
Avg. volume:
884.2K
1-year change:
81.34%
Market cap:
$2.6B
Revenue:
$398.2M
EPS:
$0.54
How Much Does Catalyst Pharmaceuticals Make?
-
How Much Are Catalyst Pharmaceuticals's Sales Annually?
CPRX Revenues are $398.2M -
How Much Profit Does Catalyst Pharmaceuticals's Make A Year?
CPRX net income is $71.4M
Is Catalyst Pharmaceuticals Growing As A Company?
-
What Is Catalyst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.23% -
What Is Catalyst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Catalyst Pharmaceuticals Stock Price Performance
-
Did Catalyst Pharmaceuticals Stock Go Up Last Month?
Catalyst Pharmaceuticals share price went up by 11.3% last month -
Did CPRX's Share Price Rise Over The Last Year?
CPRX share price rose by 81.34% over the past 1 year
What Is Catalyst Pharmaceuticals 52-Week High & Low?
-
What Is Catalyst Pharmaceuticals’s 52-Week High Share Price?
Catalyst Pharmaceuticals has traded as high as $22.20 over the past 52 weeks -
What Is Catalyst Pharmaceuticals’s 52-Week Low Share Price?
Catalyst Pharmaceuticals has traded as low as $11.89 over the past 52 weeks
Catalyst Pharmaceuticals Price To Free Cash Flow
-
Is Catalyst Pharmaceuticals Stock Overvalued?
Catalyst Pharmaceuticals is trading at a price to free cash flow ratio of 22.18 -
Is Catalyst Pharmaceuticals Stock Undervalued?
Catalyst Pharmaceuticals EV to Free Cash Flow ratio is 19.21 -
What Is Catalyst Pharmaceuticals’s Price Earnings Growth Ratio?
CPRX PEG ratio is 0.00 -
Is Catalyst Pharmaceuticals Trading At A Premium To Earnings?
Catalyst Pharmaceuticals EV to EBIT ratio is 25.71
Is It Risky To Buy Catalyst Pharmaceuticals?
-
How Much Debt Does Catalyst Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Catalyst Pharmaceuticals Have?
Cash and short term investments quarterly total is $375.7M -
What Is Catalyst Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.14
Is Catalyst Pharmaceuticals Cash Flow Positive?
-
What Is CPRX Cash Flow From Operations?
Cash flow from operations (TTM) is $196.8M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $131.4M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$131.3M
Catalyst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CPRX return on invested capital is 14.93% -
What Is Catalyst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 12.71% -
What Is CPRX Return On Equity?
ROE is a measure of profitability and is 14.93%
Catalyst Pharmaceuticals Earnings Date & Stock Price
-
What Is Catalyst Pharmaceuticals's Stock Price Today?
A single share of CPRX can be purchased today for 21.77 -
What Is Catalyst Pharmaceuticals’s Stock Symbol?
Catalyst Pharmaceuticals trades on the nasdaq under the ticker symbol: CPRX -
When Is Catalyst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Catalyst Pharmaceuticals is scheduled on November 7, 2024 -
When Is CPRX's next ex-dividend date?
Catalyst Pharmaceuticals's next ex-dividend date is May 30, 2020 -
How To Buy Catalyst Pharmaceuticals Stock?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Catalyst Pharmaceuticals Competitors
-
Who Are Catalyst Pharmaceuticals's Competitors?
Below is a list of companies who compete with Catalyst Pharmaceuticals or are related in some way:
Catalyst Pharmaceuticals Dividend Yield
-
What Is CPRX Dividend Yield?
Catalyst Pharmaceuticals’s dividend yield currently is 0% -
What Is Catalyst Pharmaceuticals’s Payout Ratio?
Catalyst Pharmaceuticals’s payout ratio is 0% -
When Did Catalyst Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 30, 2024 -
What Is Catalyst Pharmaceuticals’s Dividend Per Share?
Catalyst Pharmaceuticals pays a dividend of $0.00 per share
Catalyst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 31.45% |
| Revenue: | 23.23% | 9.69% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 30.29 |
| Upside from Last Price: | 39.12% |